Dr. Kaycee Sink to Spearhead Alzheimer’s Clinical Trials at Cogstate

Neuroscience Leader Cogstate Appoints Dr. Kaycee Sink to Drive Alzheimer’s Innovations”
Neuroscience Leader Cogstate Appoints Dr. Kaycee Sink to Drive Alzheimer’s Innovations”

Cogstate, a leading neuroscience technology company, today announced the appointment of Kaycee Sink, MD, MAS, as Chief Medical Officer. In this role, Dr. Sink will lead Cogstate’s support of clinical trials in Alzheimer’s disease and other neurodegenerative disorders, including advancing innovations to improve data quality and trial efficiency for more accurate conclusive studies.

Dr. Sink will use her extensive experience in Alzheimer’s disease drug development—gained from leading global trials and programs—to advise biopharmaceutical leaders through strategic trial design decisions, endpoint selection, and data quality considerations for cognitive and clinical outcome assessments.

Dr. Sink will also play a critical role in Cogstate’s efforts to commercialize cognitive assessment technologies within the community to support timely and more accurate diagnoses in healthcare.

See Also:  Bharat Biotech invites other companies for Covaxin production

“We are delighted to welcome Dr. Sink to Cogstate,” said Brad O’Connor, CEO of Cogstate. The medical, research, and pharmaceutical development expertise she brings will strengthen the value we offer our customers who seek to accelerate the development of new Alzheimer’s disease therapeutics, expand treatment options for patients, and make brain health awareness and action a normal part of aging.”

Dr. Sink joined Cogstate from Genentech (part of the Roche group of companies), where she was the Principal Medical Director in Neurodegeneration. There, she had leadership roles in the late-stage development of several molecules being studied for Alzheimer’s disease and other neurodegenerative disorders and digital applications for them. She joined Genentech in 2017 after 13 years on faculty at Wake Forest School of Medicine, where she rose to tenured Full Professor of Medicine, Neurology, and Public Health Sciences.

See Also:  Early Smoking Cessation Reduces Mortality Risk in NSCLC - study

“Cogstate’s commitment to bring technology and science to improve brain health assessment and to look at Alzheimer’s disease holistically is inspiring,” said Dr. Sink. “I’m thrilled to join this team of scientific and operational experts and contribute my passion to the evolving healthcare and research landscape to get the right treatment to the right patients at the right time.”

Dr. Sink is board-certified in Internal Medicine and Geriatric Medicine and has over 20 years of experience in clinical care and research on aging, Alzheimer’s disease, and other neurodegenerative disorders. She obtained her medical degree at the University of California, San Francisco, and subsequently trained in internal medicine, followed by clinical and research fellowships in geriatrics, also at UCSF.

Dr. Sink continues to see patients and teach in the Memory Assessment Clinic as adjunct faculty at Wake Forest School of Medicine in Winston Salem, NC.

About Emma Grace 156 Articles
Emma Grace is a well-known author with over 5 years of experience. She has written much informative content for a Perfect Essay Writing website. She has a lot of creative potential and understands how to make compelling content.

Be the first to comment

Leave a Reply

Your email address will not be published.